Cathie Wood has never been one to shy away from bold bets, and her latest move confirms that reputation. The CEO of Ark Invest deployed $21.3 million across multiple funds to buy shares of Space Exploration Technologies Corp. (NASDAQ: SPCX) as the stock cratered 45% from its post-IPO record high. With Wall Street’s median 12-month price target sitting at $243.81 — representing 111.5% upside from the current close — Wood’s contrarian purchase is drawing intense scrutiny from analysts and retail investors alike.
Ark Invest’s Deep Conviction in SpaceX
The Ark Innovation ETF (ARKK) is no stranger to concentrated, high-conviction positions. Roughly half of the fund’s total assets are allocated to just 10 companies, including Tesla (TSLA), Tempus AI (TEM), and CRISPR Therapeutics (CRSP). SpaceX currently accounts for approximately 4.5% of the fund’s invested capital, placing it firmly among Ark’s top holdings.
Wood’s investment philosophy centers on disruptive innovation and long-duration growth themes. SpaceX — Elon Musk’s rocket and satellite internet enterprise — fits squarely within that framework. Following its highly anticipated IPO, shares initially surged well above $200 before enduring a brutal correction that pushed the stock below its $135 IPO price. Rather than retreating, Wood treated the drawdown as an opportunity, purchasing $21.3 million worth of SpaceX shares across multiple Ark-managed funds.
Wall Street’s Verdict: Massive Upside but Wide Uncertainty
Nearly 30 analysts currently cover SPCX, and the consensus strongly supports Wood’s decision. The median 12-month price target of $243.81 implies roughly 111% upside from the stock’s current trading level. However, the range of analyst estimates reveals just how polarizing SpaceX remains as a public company investment.
On the bullish end, one analyst has set an extraordinary $800 price target. On the bearish side, at least one analyst rates the stock a “sell” with a target of just $115, suggesting further downside risk. This enormous spread — from $75 to $800 in some models — underscores the speculative nature of valuing a company whose revenue trajectory depends heavily on unproven, next-generation business lines.
Morgan Stanley’s Explosive Revenue Forecasts
Morgan Stanley, which served as one of the lead underwriters for SpaceX’s IPO, has reiterated a $300 price target. The bank projects SpaceX’s revenue will skyrocket from $18.7 billion in 2025 to $319 billion by 2030 and reach a staggering $3.3 trillion by 2040. The bank attributes nearly all of this anticipated growth to SpaceX’s AI division — the same segment that SpaceX itself says represents the core of a $28.5 trillion total addressable market.
Investors should weigh Morgan Stanley’s projections with context. As an IPO underwriter, the bank has a financial incentive to maintain bullish coverage. SpaceX remains unprofitable and will likely need to raise additional capital in the future, meaning Morgan Stanley stands to benefit from continued deal flow. Even Morgan Stanley’s own analysts concede that their price outcomes range from $75 to $600 over the next year — a remarkably wide band that highlights genuine uncertainty.
SpaceX’s Enormous Ambitions — and the Risks
In its IPO prospectus, SpaceX made what may be the boldest claim in corporate history: “We believe we have identified the largest actionable total addressable market in human history,” estimating its total growth opportunity at $28.5 trillion. Compared to its current $1.5 trillion market capitalization, the company argues its shares remain deeply undervalued relative to long-term potential.
More than 90% of that claimed addressable market centers on artificial intelligence, not traditional aerospace or Starlink satellite internet. This pivot toward AI-driven revenue has excited growth investors but also introduced execution risk. SpaceX must prove it can commercialize AI at scale while simultaneously managing the capital demands of its launch and satellite operations.
What This Means for Investors
Cathie Wood’s $21.3 million SpaceX purchase signals deep institutional conviction in the company’s long-term trajectory. Wall Street broadly agrees, with the consensus price target implying more than double the current share price. However, the wide dispersion of analyst estimates — and the fact that SpaceX remains unprofitable — means the stock carries significant risk alongside its potential reward.
For investors considering exposure to SPCX, the key question is whether SpaceX can deliver on its AI ambitions at a pace that justifies its $1.5 trillion valuation. Wood is clearly betting yes. Whether that bet pays off will depend on execution, capital allocation, and the broader trajectory of AI adoption over the next decade.
Frequently Asked Questions (FAQ)
1. Why did SpaceX stock fall 45% from its record high?
After an explosive post-IPO rally that pushed shares well above $200, SpaceX experienced a sharp correction driven by profit-taking, broader market volatility, and investor concerns about the company’s lack of profitability. The stock eventually fell below its $135 IPO price, reflecting the speculative nature of newly public companies with ambitious but unproven growth projections.
2. What is SpaceX’s ticker symbol, and where does it trade?
Space Exploration Technologies Corp. trades on the Nasdaq under the ticker symbol SPCX. The stock became publicly available following its landmark IPO, which was underwritten by major banks including Morgan Stanley.
3. Should I follow Cathie Wood’s trades and buy SpaceX stock?
While Cathie Wood’s Ark Invest has a track record of identifying disruptive growth companies early, following any single investor’s trades without conducting independent research carries risk. SpaceX remains unprofitable, and analyst price targets range from $75 to $800, reflecting extreme uncertainty. Investors should evaluate their own risk tolerance, portfolio diversification, and investment horizon before making any decisions.
